These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28556289)

  • 1. Influence of regular reporting on local Pseudomonas aeruginosa and Acinetobacter spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Clin Pharm Ther; 2017 Oct; 42(5):585-590. PubMed ID: 28556289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
    Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
    Lee K; Kim MN; Kim JS; Hong HL; Kang JO; Shin JH; Park YJ; Yong D; Jeong SH; Chong Y;
    Yonsei Med J; 2011 Sep; 52(5):793-802. PubMed ID: 21786445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.
    Friedland I; Stinson L; Ikaiddi M; Harm S; Woods GL
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):245-50. PubMed ID: 12729994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to β-lactams and carbapenems in patients with healthcare-associated infections.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Glob Antimicrob Resist; 2018 Jun; 13():60-64. PubMed ID: 29154953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors.
    Djordjevic Z; Folic MM; Zivic Z; Markovic V; Jankovic SM
    Am J Infect Control; 2013 Dec; 41(12):1182-7. PubMed ID: 23726656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
    Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological profile and antibiotic resistance: comparison of findings in a burn intensive care unit, other intensive care units, and the hospital services unit of a single center.
    Yildirim S; Nursal TZ; Tarim A; Torer N; Noyan T; Demiroglu YZ; Moray G; Haberal M
    J Burn Care Rehabil; 2005; 26(6):488-92. PubMed ID: 16278563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit.
    Djordjevic ZM; Folic MM; Jankovic SM
    J Infect Public Health; 2017; 10(6):740-744. PubMed ID: 28189513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter Spp: Resistance and therapeutic decisions at the turn of the novel millennium.
    Saeed M; Rasheed F; Hussain S; Riaz S; Hanif A; Ahmad M; Ain N; Khan F; Iram S; Arshad M
    Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2749-2754. PubMed ID: 30587490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance Rates of Intra-Abdominal Isolates from Intensive Care Units and Non-Intensive Care Units in the United States: The Study for Monitoring Antimicrobial Resistance Trends 2010-2012.
    Hackel MA; Badal RE; Bouchillon SK; Biedenbach DJ; Hoban DJ
    Surg Infect (Larchmt); 2015 Jun; 16(3):298-304. PubMed ID: 25894976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.
    Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii55-63. PubMed ID: 18819980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V; Fica A; Silva M; Thompson L
    Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.